Dimensional Fund Advisors
XERS icon

Dimensional Fund Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Dimensional Fund Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Buy
+1,073,639
New +$6.86M ﹤0.01% 2374
2024
Q3 		– Sell
-48,663
Closed -$109K – 3396
2024
Q2 		$109K Sell
48,663
-6,437
-12% -$13K ﹤0.01% 3241
2024
Q1 		$122K Buy
+55,100
New +$143K ﹤0.01% 3241
2022
Q3 		– Sell
-45,082
Closed -$69K – 3532
2022
Q2 		$69K Buy
45,082
+5,688
+14% +$12K ﹤0.01% 3369
2022
Q1 		$101K Sell
39,394
-30,478
-44% -$74.5K ﹤0.01% 3393
2021
Q4 		$204K Buy
69,872
+21,402
+44% +$46.2K ﹤0.01% 3338
2021
Q3 		$119K Sell
48,470
-31,717
-40% -$92.1K ﹤0.01% 3410
2021
Q2 		$326K Buy
+80,187
New +$306K ﹤0.01% 3247

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors's XERS Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 1,073,639 shares worth $8.5M. The stake represents ﹤0.01% of the portfolio and ranks #2374 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in XERS as recently as Q2 2024.

Dimensional Fund Advisors first reported a position in XERS in Q2 2021 and has held it in 8 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Dimensional Fund Advisors held 1,073,639 shares of Xeris Biopharma Holdings worth $8.5M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Dimensional Fund Advisors position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2374 holding.
  • Dimensional Fund Advisors first reported a position in Xeris Biopharma Holdings in Q2 2021 and has held it in 8 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.